CHINA CONST BK
✦ StockVane Quant Insights how this is computed
- Twelve-month momentum in the top 27% of the universe, above its 200-day average.
- Signal has read BUY for 2 weeks.
- Price is below its 20-day average and above its 60-day average.
- The 20-day average is above the 60-day average, a short-term uptrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Price chart
Anonymous reader poll. Unscientific, not investment advice.
Performance
Key statistics
Price & volume
- Prev close
- 24.70
- Open
- 24.84
- Day range
- 24.83 - 24.89
- Avg price
- --
- Volume
- 3.82K
- Turnover
- 95.05K
- Turnover ratei
- 0.00%
- Amplitudei
- 0.24%
- 52-week rangei
- 18.21 - 25.44
Valuation
- P/Ei
- --
- P/E (TTM)i
- 6.69
- P/Bi
- 0.61
- EPSi
- 3.72
- Book value / shi
- 40.90
- Net profit
- --
- Net assets
- --
Share structure
- Market cap
- 317.84B
- Float capi
- --
- Shares out
- 12.77B
- Float sharesi
- 12.77B
Dividend & listing
- Div yield (TTM)i
- 4.61%
- Dividend (TTM)
- 1.14
- Listing date
- 1970-01-01
2.2% below the 52-week high
Frequently asked questions
What is the current stock price of CHINA CONST BK (CICHY)?
CHINA CONST BK last traded at 24.89. The quote on this page refreshes every few seconds while US markets are open.
What is CHINA CONST BK's market cap?
About 317.84B.
What is the P/E ratio of CHINA CONST BK?
The trailing twelve-month P/E is 6.69. The Valuation tab shows it against the stock's own five-year range.
Does CHINA CONST BK pay a dividend?
Yes. The trailing dividend yield is 4.61%. See the Dividends tab for the full payment history.
What is CHINA CONST BK's StockVane Quant Rating?
The StockVane Momentum strategy currently rates CHINA CONST BK a B (Buy). Twelve-month momentum in the top 27% of the universe, above its 200-day average. Not investment advice.
Quote time 2026-10-12 05:30:29 · For reference only, not investment advice and not tailored to your situation.
CHINA CONST BK discussion 0 comments